Nesinamet Tablet 12.5/500 mg
Alogliptin Benzoate 17mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 201501047 · Approved 2015.02.27
This product's status changed to Approval withdrawn on 2025.05.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication assists in blood glucose control for patients with type 2 diabetes, supporting dietary and exercise therapy. The combination of alogliptin and metformin effectively improves blood sugar levels to aid in diabetes management. Therefore, this medication is used to improve blood glucose control.
The dose of this medicine should be adjusted according to efficacy and tolerability, without exceeding the maximum recommended daily doses of each component: alogliptin 25mg and metformin 2000mg. The initial dose of this medicine is determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. Patients not currently receiving metformin The initial dose is 1 tablet of this medicine 12.5/500mg twice daily; the dose may be increased to 1 tablet of this medicine 12.5/1000mg twice daily. 2. Patients with inadequate glycemic control on metformin monotherapy The initial dose of this medicine is alogliptin 12.5mg twice daily (total daily dose 25mg) and the patient's current dose of metformin, according to the patient's current treatment regimen. 3. Patients with inadequate glycemic control on combination therapy with metformin and pioglitazone The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. 4. Patients with inadequate glycemic control on combination therapy with metformin and insulin The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. When this medicine is administered concomitantly with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. 5. Substitution for combination therapy with alogliptin and metformin When switching from combination therapy with alogliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of alogliptin and metformin.
This medication is a diabetes treatment that contains metformin and alogliptin, which helps in blood glucose control. This medication should not be used in patients with impaired kidney function or severe heart disease. If kidney function is poor, the drug may accumulate in the body and lead to dangerous conditions. It should be used with caution in patients with acute infections, during and after surgery, or those with poor nutritional status, and may be temporarily discontinued if necessary. While taking this medication, lactic acidosis, a serious side effect, can occur rarely, so if symptoms such as fatigue, muscle pain, difficulty breathing, or abdominal pain arise, immediate consultation with a hospital is required. Acute pancreatitis can occur; hence, if severe abdominal pain or vomiting symptoms appear, immediate treatment should be sought. This medication may cause allergic reactions; therefore, if symptoms such as rash, urticaria, or difficulty breathing occur, one should stop taking the medication and visit a hospital immediately. In cases of liver dysfunction, use of this medication should be avoided or approached with caution, and if there are any abnormal symptoms in liver function, immediate consultation with medical personnel is necessary. Regular kidney function tests should be conducted, and if kidney function deteriorates, the medication should be discontinued. Before and after tests using radiographic contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. Excessive alcohol consumption should be avoided while taking this medication, as alcohol can increase the risk of drug side effects. Vitamin B12 levels may decrease; therefore, regular blood tests are advisable, and supplementation therapy should be administered if necessary. If taken in combination with other glucose-lowering agents, symptoms of hypoglycemia may appear, so blood glucose levels must be monitored carefully. In elderly patients, kidney function deterioration is common, hence dosage adjustment and regular kidney function tests are necessary. In cases of overdose, gastrointestinal symptoms or lactic acidosis may occur, so one should visit a healthcare facility immediately for appropriate treatment. This medication is not administered to pregnant or breastfeeding women. Safety in children has not been established, so it is advisable not to use it.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy and safety for a long time.
Pale yellow, biconvex, rectangular film-coated tablet
60 tablets (10 tablets/PTP x 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Alogliptin Benzoate 17mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
Alogliptin Benzoate 17mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Celltrion Healthcare Co., Ltd.
Alogliptin Benzoate 17mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Alogliptin Benzoate 34mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Alogliptin Benzoate 17mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Alogliptin Benzoate 17mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationAlogliptin Benzoate 17mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationAlogliptin Benzoate 17mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.